Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Archives of Neurology|January 16, 2008
Reduced Purkinje cell number in essential tremor: a postmortem studyJordan E Axelrad, Elan D Louis, Lawrence S Honig, et al.
Crohn'S & Colitis 360|February 13, 2023
Real-World Effectiveness and Safety of Ustekinumab for Ulcerative Colitis From 2 Tertiary IBD Centers in the United StatesSimon J Hong, Noa Krugliak Cleveland, Shintaro Akiyama, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Tofacitinib uptake by patient-derived intestinal organoids predicts individual clinical responsivenessKyung Ku Jang, Defne Ercelen, Jing Yu Carolina Cen Feng, et al.
Eclinicalmedicine|July 26, 2021
Early life exposures and the risk of inflammatory bowel disease: Systematic review and meta-analysesManasi Agrawal, João Sabino, Catarina Frias-Gomes, et al.
Inflammatory Bowel Diseases|October 13, 2018
Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficileDana J Lukin, Garrett Lawlor, David P Hudesman, et al.
Therapeutic Advances in Gastroenterology|August 22, 2025
Risk of malnutrition increases in the year prior to surgery among patients with inflammatory bowel diseaseVasantham Chaudhary, Frank R Chung, Olivia Delau, et al.
Therapeutic Advances in Gastroenterology|May 1, 2023
Risk factors for incomplete telehealth appointments among patients with inflammatory bowel diseaseKatherine L Stone, Emma Kulekofsky, David Hudesman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 15, 2019
Hormone Therapy for Cancer Is a Risk Factor for Relapse of Inflammatory Bowel DiseasesJordan E Axelrad, Ahmad Bazarbashi, James Zhou, et al.
Therapeutic Advances in Gastroenterology|November 9, 2022
COVID-19 is not associated with worse long-term inflammatory bowel disease outcomes: a multicenter case-control studySimon J Hong, Sumona Bhattacharya, Aiya Aboubakr, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 20, 2024
Safety of Immunosuppression in a Prospective Cohort of Inflammatory Bowel Disease Patients With a HIstoRy of CancEr: SAPPHIRE RegistrySteven H Itzkowitz, Yue Jiang, Cristina Villagra, et al.
Pageof 8